Pharmacokinetics of eprinomectin in plasma and milk following topical administration to lactating dairy cattle

Abstract

The pharmacokinetics and mammary excretion of eprinomectin were determined in cattle following topical administration at a dose rate of 0·5 mg kg–1. The kinetics of plasma and milk concentrations were analysed using a one-compartment model. The maximum plasma concentration of 43·76 ng ml–1occurred 2·02 days post administration, and the mean residence time was 4·16 days. Eprinomection was detected in the milk at the first sampling time and thereafter for at least 15 days. Comparison of the milk and plasma data demonstrated the parallel disposition of the drug in the milk and plasma with a milk / plasma concentration ratio of 0·102±0·048. The amount of drug recovered in the milk during this period was 0·109% ± 0·038 of the total administered dose. This very low extent of mammary excretion resulted in low concentrations of eprinomectin in milk. This supports the permitted use in lactating cattle, as the maximum level of residue in milk did not exceed the maximum acceptable limit of 30 ng ml–1.